For the quarter ending 2025-11-28, AEHR had $6,327K increase in cash & cash equivalents over the period. -$1,638K in free cash flow.
| Cash Flow | 2025-11-28 | 2025-08-29 |
|---|---|---|
| Net income (loss) | -3,230 | -2,084 |
| Stock-based compensation expense | 1,841 | 1,671 |
| Depreciation and amortization | 690 | 743 |
| Deferred income taxes | -1,201 | -761 |
| Amortization of operating lease right-of-use assets | 181 | 179 |
| Accounts receivable | -2,751 | -1,140 |
| Inventories | 872 | -218 |
| Prepaid expenses and other current assets | -532 | -1,576 |
| Accounts payable | 287 | -2,401 |
| Accrued expenses | -988 | 505 |
| Deferred revenue | -676 | -863 |
| Operating lease liabilities | -482 | -215 |
| Income taxes payable | -4 | 10 |
| Net cash provided by (used in) operating activities | -1,171 | -282 |
| Purchases of property and equipment | 467 | 1,391 |
| Payments for business acquisition, net of cash and cash equivalents acquired | 1,801 | 0 |
| Net cash used in investing activities | -2,268 | -1,391 |
| Proceeds from issuance initial public offering | 9,371 | - |
| Proceeds from issuance of common stock under employee plans | 897 | 170 |
| Shares repurchased for tax withholdings on vesting of restricted stock units | 491 | 328 |
| Net cash used in financing activities | 9,777 | -158 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -11 | 9 |
| Net decrease in cash, cash equivalents and restricted cash | 6,327 | -1,822 |
| Cash and cash equivalents at beginning of period | 24,658 | 26,480 |
| Cash and cash equivalents at end of period | 30,985 | 24,658 |
AEHR TEST SYSTEMS (AEHR)
AEHR TEST SYSTEMS (AEHR)